Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality
Rasmus Rivinius,1 Matthias Helmschrott,1 Arjang Ruhparwar,2 Ann-Kathrin Rahm,1,3 Fabrice F Darche,1 Dierk Thomas,1 Tom Bruckner,4 Philipp Ehlermann,1 Hugo A Katus,1 Andreas O Doesch1,5 1Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Heidelberg, 2Department of Ca...
Main Authors: | Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, Doesch AO |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-10-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/chronic-digitalis-therapy-in-patients-before-heart-transplantation-is--peer-reviewed-article-TCRM |
Similar Items
-
Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation
by: Rivinius R, et al.
Published: (2017-06-01) -
COPD in patients after heart transplantation is associated with a prolonged hospital stay, early posttransplant atrial fibrillation, and impaired posttransplant survival
by: Rivinius R, et al.
Published: (2018-09-01) -
Combined amiodarone and digitalis therapy before heart transplantation is associated with increased post‐transplant mortality
by: Rasmus Rivinius, et al.
Published: (2020-10-01) -
The influence of surgical technique on early posttransplant atrial fibrillation — comparison of biatrial, bicaval, and total orthotopic heart transplantation
by: Rivinius R, et al.
Published: (2017-03-01) -
Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation
by: Rivinius R, et al.
Published: (2016-02-01)